• Meningitis Outbreak Places Spotlight on FDA's Regulation of Compounding Pharmacies

    The US Food and Drug Administration's (FDA) regulation of compounding pharmacies has come under fire in the wake of a drug safety problem involving steroid injection shots infected with the meningitis virus. The tainted drugs, traced back to a Massachusetts pharmacy, have already been implicated in five deaths and 35 cases across 23 states-a number officials said is likely to rise in light of the scope of the drug's distribution. But almost as much as the crisis itself,...